Table 2.
The frequency of HIV-1 drug resistance mutations among the participants
Drug resistance mutations | Total (%) | HIV-1 Strain types | |
---|---|---|---|
CRF08_BC (%) | Others (%) | ||
NRTIs | |||
M41L | 2 (0.6) | 2 (0.6) | 0 |
A62V | 1 (0.3) | 1 (0.3) | 0 |
K65KR | 5 (1.5) | 4 (1.2%) | 1 (0.3) |
D67DN | 2 (0.6) | 2 (0.6) | 0 |
T69D | 1 (0.3) | 1 (0.3) | 0 |
V75VI | 1 (0.3) | 0 | 1 (0.3) |
T215D | 1 (0.3) | 1 (0.3) | 0 |
NNRTIs | |||
K101E | 3 (0.9) | 2 (0.6) | 1 (0.3) |
K103N/KN/KQR | 3 (0.9) | 3 (0.9) | 0 |
V106I/VI | 9 (2.8) | 5 (1.6) | 4 (1.2%) |
E138A/EA/G/EG/K/R | 46 (14.3) | 45 (14.0) | 1 (0.3) |
V179E/T/D/DE/VD/VDE | 44 (13.7) | 28 (8.7) | 16 (5.0) |
Y188L/N/YC/YF | 4 (1.2) | 4 (1.2%) | 0 |
G190A | 1 (0.3) | 1 (0.3) | 0 |
H221Y/HY | 3 (0.9) | 1 (0.3) | 2 (0.6) |
P225H | 3 (0.9) | 3 (0.9) | 0 |
PIs | |||
D30DN | 1 (0.3) | 1 (0.3) | 0 |
I47IV | 1 (0.3) | 1 (0.3) | 0 |
I50IV | 1 (0.3) | 0 | 1 (0.3) |
V82VL | 1 (0.3) | 1 (0.3) | 0 |
PR Accessory | |||
K20T | 1 (0.3) | 1 (0.3) | 0 |
L24LF | 1 (0.3) | 1 (0.3) | 0 |
V32LV | 1 (0.3) | 0 | 1 (0.3) |
L33F | 1 (0.3) | 0 | 1 (0.3) |
I47IK | 1 (0.3) | 0 | 1 (0.3) |
G48GE | 1 (0.3) | 1 (0.3) | 0 |
I50IT | 1 (0.3) | 1 (0.3) | 0 |
Q58QE | 1 (0.3) | 1 (0.3) | 0 |
I84IK | 1 (0.3) | 1 (0.3) | 0 |
L89MV | 1 (0.3) | 0 | 1 (0.3) |